New egg-maturing technique could slash IVF costs and risks
NCT ID NCT06984081
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a milder form of IVF called CAPA in-vitro oocyte maturation (IVM). Instead of giving women strong hormones to stimulate egg growth, eggs are collected early and matured in a lab. The goal is to reduce side effects and costs for women with infertility or those preserving fertility before cancer treatment. The trial will enroll 100 women aged up to 50.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CAPA IVM (a procedure where eggs are matured outside the body)
What this could lead to
If successful, this could offer a safer, lower-cost alternative to standard IVF for women with infertility or those needing fertility preservation.
What could go wrong
This is an early-stage study with only 100 participants, so results may not apply to everyone. The procedure may not produce enough mature eggs for successful pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY, FEMALE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Prince of Wales Hospital
RECRUITINGHong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••